Your position:m.limatoxi.com >> EN >> EN >> Formulation >> Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure >> article
 
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
Editor:xuezhe     Clicks:0    Date:2023-2-16 13:54:25
Keyword: Dapagliflozin
Healthoo Information:
Dapagliflozin is approved in the EU for the treatment of symptomatic chronic heart failure
 
 E-mail:xuezhe@healthoo.com
 Tel.:86-10-68032463
  Our services:
 China Im\Ex data service
 Service fees of Chinese Vision
 Our service items
Online information introduction
Monthly information
Relative Information
  • Dapagliflozin is approved in the EU for the treatment of symptomatic c...
  • Linkai to build Dapagliflozin etc. APIs project
  • Address: Suite 13F,NO2 Building, FuXing International, TianHua North Street, Yizhuang, Daxing District, Beijing, P.R. China
    Tel:+86-10-68032463
    Baidu
    map